BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28374160)

  • 21. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
    Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
    Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of NBN molecular variants in pediatric astrocytic tumors.
    Piekutowska-Abramczuk D; Ciara E; Popowska E; Grajkowska W; Dembowska-Bagińska B; Kowalewska E; Czajńska A; Perek-Polnik M; Roszkowski M; Syczewska M; Krajewska-Walasek M; Perek D; Chrzanowska KH
    J Neurooncol; 2010 Jan; 96(2):161-8. PubMed ID: 19629396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
    Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
    Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
    Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
    Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
    Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
    Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
    Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
    PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
    Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
    Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple trichoepitheliomas associated with a novel heterozygous mutation in the CYLD gene as an adjunct to the histopathological diagnosis.
    Reuven B; Margarita I; Dov H; Ziad K
    Am J Dermatopathol; 2013 Jun; 35(4):445-7. PubMed ID: 23694822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized molecular modeling for pinpointing associations of protein dysfunction and variants associated with hereditary cancer syndromes.
    Macklin S; Mohammed A; Jackson J; Hines SL; Atwal PS; Caulfield T
    Mol Genet Genomic Med; 2018 Sep; 6(5):805-810. PubMed ID: 30043523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent pathogenic variations in patients with hereditary cancer syndromes.
    Agaoglu NB; Doganay L
    Eur J Med Genet; 2021 Dec; 64(12):104366. PubMed ID: 34637943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heterozygous carriers of Slavic mutation 657del5 of NBN gene in patients with colorectal cancer].
    Seemanová E; Hoch J; Seeman P
    Cas Lek Cesk; 2011; 150(2):97-9. PubMed ID: 21560448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
    Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common missense variant in BRCA2 predisposes to early onset breast cancer.
    Górski B; Narod SA; Lubinski J
    Breast Cancer Res; 2005; 7(6):R1023-7. PubMed ID: 16280055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
    Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
    Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline Genetic
    Escherich C; Chen W; Li Y; Yang W; Nishii R; Li Z; Raetz EA; Devidas M; Wu G; Nichols KE; Inaba H; Pui CH; Jeha S; Camitta BM; Larsen E; Hunger SP; Loh ML; Yang JJ
    Res Sq; 2023 Jul; ():. PubMed ID: 37503171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report.
    Abe K; Ueki A; Urakawa Y; Kitago M; Yoshihama T; Nanki Y; Kitagawa Y; Aoki D; Kosaki K; Hirasawa A
    Hered Cancer Clin Pract; 2021 Jan; 19(1):5. PubMed ID: 33413558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
    Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
    PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.